Methyldopa, which released in 1960, is one of the most popular blood pressure lowering drugs. Taking this medicine for high blood pressure, it seems that the effect drug in blood pressure duct ions convection to alpha-methyl is nor epinephrine. Alpha-methyl nor epinephrine from thus reducing central blood pressure is. This work reports an investigation of an antihypertensive drug methyldopa with the combined density functional theory (DFT) and its structure was optimized at B3LYP, BLYP and MP2(3-21G * ,6-31G,6-31G * ) levels and the molecular structure in different solvents (SCRF calculation), NMR parameters were calculated using DFT at B3LYP, BLYP and MP2(3-21G * ,6-31G,6-31G * ) basis set. And finally we calculated natural bond orbital (NBO) parameters for this structure.
Introduction
Micro dialysis technique is a useful method for in vivo sampling of neurotransmitters, drugs, and metabolites (Benveniste and Hu¨ttemeier, 1990) . The applicability to the study of drug metabolism and pharmacokinetic in rats has been demonstrated in several reports (Chen and Steger, 1993; Elmquist and Sawchuk, 1997) . Methyldopa (MD) exerts its antihypertensive effect through a central mechanism that involves the biotransformation to methyl norepinephrine (Robertson et al., 1984; van Zwieten et al., 1984) . This drug may inhibit the aromatic amino acid decarboxylase, an enzyme in the biosynthetic pathway of catecholamine's (Ledoux et al., 1983) . Sino aortic denervations (SAD) performed according to Krieger's procedure induces a labile hypertension in rats, alteration in serotonergic and cholinergic pathways and an elevation of the peripheral sympathetic tone (Nakamura and Nakamura, 1981; Giarcovich-Mart´ınez et al., 1983; Alexander et al., 1976 Alexander et al., , 1980 . Alexander et al. (1988) , reported that the striatal concentration of dopamine and tyrosine hydroxyls activity of the nigrostriatal system are decreased after differentiation of arterial baroreceptor nerves. Moreover, it was found that 3,4dihydroxyphenylaceticacid (DOPAC) and HVA levels in freely moving SAD rats were lower than in sham operated (SO) rats. In our laboratory, we have seen altered pharmacological responses to clonidine and MD in SAD rats (Taira et al., 1983; Taira and Enero, 1989) . Moreover, in a recent study by using the micro dialysis technique, different kinetic profiles of MD in dialysates from arterial blood or striatum were seen in SO and SAD rats (Opezzo et al., 2000) . Duncan et al. (1991) and Mizuchi et al., 1983 have demonstrated that the regional brain distribution of the drugs and their accumulation may be significantly different. Therefore, it is possible that the sin aortic denervation modifies the pharmacokinetic profile of MD in different brain structures and this could modify the pharmacological action of this drug on dopaminergic neurotransmission. The aim of this work was to study the time course of MD in brain by using the micro dialysis technique in order to make a pharmacokinetic approach in chloralose-urethane anesthetized SAD rats. We measured the effect of MD on the dopaminergic metabolism through its action on DO-PAC and HVA dialysate levels in SO and SAD rats.
Methyldopa, hydroxy-a-methyl-L-tyrosine, is an antihypertensive agent that primarily acts within the central nervous system as an a-adrenergic agonist (Fink et al., 1998) . Methyldopa is taken up by adrenergic neurons,where it is decarboxylated and hydroxylated to form the false transmitter, a-methylnoradrenaline, which is less active than noradrenalin on a-receptors and thus less effective in causing vasoconstriction. In this paper, we describe a fast, sensitive and specific liquid chromatography-tandem mass specific (LC-MS-MS) method for the quantization of methyldopa using dopa-phenyl D3 as an internal standard (I.S). The method was applied to a bioequivalence study of two oral formulations of methyldopa (500 mg tablet, legrand metildopa from Ems industrial pharmaceutical, Brazil, as test formulation and Aldomet from prodome Quimica e faemaceutica, Brazil as reference Methyldopa/B3LYP/3-21G * (gas) 000.0000
Methyldopa/B3LYP/6-31G(gas) À2384.0299 Methyldopa/B3LYP/6-31G * (gas) À2581.3749 Methyldopa/BLYP/3-21G * (gas) À2604.7405 Methyldopa/BLYP/6-31G(gas) À2765.666 Methyldopa/BLYP/6-31G * (gas) À5052.5005 Methyldopa/MP2/3-21G * (gas) À5175.2312 Methyldopa/MP2/6-31G(gas) À5199.7764 Methyldopa/MP2/6-31G * (gas) À5335.2635 Methyldopa/B3LYP/3-21G * (water) 000.0000
Methyldopa/B3LYP/6-31G(water) À2385.6486 Methyldopa/B3LYP/6-31G * (water) À2579.5178 Methyldopa/BLYP/3-21G * (water) À2591.3477 Methyldopa/BLYP/6-31G(water) À2757.9845 Methyldopa/BLYP/6-31G * (water) À5041.0206 Methyldopa/MP2/3-21G * (water) À5168.3198 Methyldopa/MP2/6-31G(water) À5193.4468 Methyldopa/MP2/6-31G * (water) À5332.1585 formulation). Methyldopa (MD) is an antihypertensive that controls the sympathetic nervous system via a central action (Oparil, 1982) . This medication is typically administered to patients with heart failures, renal failures, and diabetes (Universal Pharmaceutical Co. Aldomet Tablets, 2008) . Furthermore, it is one of the few antihypertensives indicated in pregnancy-induced hypertension (Universal Pharmaceutical Co. Aldomet Tablets, 2008; Ellenbogen et al., 1986) . A structural feature of the drug is an amino acid skeleton with a catechol group as found in DOPA, an anti-Parkinsonism medication. In fact MD possesses a structure in which an ahydrogen found in DOPA is replaced by a methyl group (Fig. 1 ). It was reported by Garfinkel in 1972 that DOPA is degraded by mixing it with banana pulp (Garfinkel, 1972) . He performed an investigation whereby the powdered DOPA was mixed with banana at room temperature, and changes in the coloration of the mixture resulted -from a faint pink, followed by a bright brown, then a dark brown, then a gray, and, finally a liquorice-like black. Currently, there is substantial proof that indicates that the alteration of color is caused by polyphenoloxidase (catechol oxidase; EC 1.10.3.1), an enzyme related with melanin biosynthesis, and found in banana pulp (Yang et al., 2000; Sojo et al., 1999 Sojo et al., , 2000 .
Computational details
In our current study, extensive quantum mechanical calculations (Monajjemi and Noei, 2010; Mollaamin et al., 2011; of structure of methyldopa (see Fig. 1 ), solvent effects on structure of methyldopa and calculations of NMR parameters have been Performed on a Pentium-4 based system using GAUSSIAN 98 program. At first, we have modeled the structure of methyldopa with Chem. office package and then optimized at the DFT level of theory with 3-21G * ,6-31G and 6-31G * basis set. After full optimization of those structures, we have calculated NMR parameters at the levels of B3LYP, BLYP and MP2(3-21G,6-31G,6-31G * ) theory and theoretically explored the solvent effects (water, methanol, ethanol) on the structure of methyldopa. All relative energy values and NMR shielding parameters were calculated supposing gauge-included atomic orbital (GIAO) method.
This process involves sequential transformation of nonorthogonal atomic orbital's (AOs) to those of natural atomic orbital's (NAOs), natural hybrid orbital's (NHOs), and NBOs. Each of these localized basis sets is complete and describes the wave functions in the most economic method since electron density and other properties are described by the minimal amount of .Filled orbital sin the most rapidly convergent way. Filled NBOs describe the hypothetical, strictly localized Lewis structure. The interactions between filled and anti Table 3 -17 Second order perturbation theory analysis of Fock matrix in NBO basis threshold for printing: B3LYP/3-21G * method.
Phase
Donor NBO (i) Acceptor NBO (j) E(2) (kcal/mol)
BD * (1)C10-H22 1.00 
bonding (or Rydberg) orbital's represent the deviation of the molecule from the Lewis structure and can be used as the measure of delocalization. This non covalent bonding-anti bonding interaction can be quantitatively described in terms of NBO approach that is expressed by means of the second-order perturbation interaction energy (E (2) ) Weinhold, 1983, 1985; Foster and Weinhold, 1980 . This energy represents the estimate of the off diagonal NBO Fock matrix elements. It can be deduced from the second-order perturbation approach (Chocholousova et al., 2004) .
where q i is the donor orbital occupancy, e i , e j are diagonal elements (orbital energies) and F(i, j) is the off-diagonal NBO Fock matrix element.
Result and discussion
In this paper DFT and MP2 method with 3-21G * ,6-31G and 6-31G * basis set were employed for investigating the structure's optimization and energy minimization of methyldopa, (Fig. 1 ) which have been summarized in Tables 3-1-3-4. The MP2 and DFT energies are of particular interest because they provide results for interactions appearing in solvent medium considered in this letter, which are in accord with the biological behavior of methyldopa. Furthermore, recent papers often tend to ask about the role of water solvent effect on the stability of methyldopa structure. The detailed results of relative energy values for methyldopa structure in gas, water, CH 3 OH and CH 3 CH 2 OH solvents optimized at B3LYP, BLYP and MP2 levels of theory with 3-21G * ,6-31G and 6-31G * basis set are summarized in Tables 3-1-3-4. Regarding most of the systems studied experimentally are in solution, the formulation of satisfactory theoretical models for solvated systems has been the object of continuously increasing interest, therefore, abinitio calculation of nuclear magnetic shielding has become an indispensable aid in the Table 3 -20 Second order perturbation theory analysis of Fock matrix in NBO basis threshold for printing: BLYP/3-21G * method.
Phase
Donor NBO (i) Acceptor NBO (j) E(2) (kcal/mol) Gas LP(1)O11 BD * (1)C2-C3 3.90 LP(2)O11 BD * (2)C1-C2 0.23 LP(1)O14 BD * (1)C8-C9 1.79 LP(1)O14 BD * (1)C9-O13 0.70 LP(2)O14 BD * (1)C8-C9 17.18 LP(2)O14 BD * (1)C9-O13 37.95 LP(1)N15 BD * (1)C7-C8 1.60 LP(1)N15 BD * (1)C8-C10 6.810 LP(1)N15 BD * (1)C10-H22 0.87
BD * (2)C1-C2 29.06 LP(1)O14 BD * (1)C8-C9 1.77 LP(1)O14 BD * (1)C9-O13 0.7 LP(2)O14 BD * (1)C8-C9 16.97 LP(2)O14 BD * (1)C9-O13 37.97 LP(1)N15 BD * (1)C7-C8 1.59 LP(1)N15 BD * (1)C8-C10 6.47 LP(1)N15 BD * (1)C10-H22 0.86 
BD * (1)C8-C10 8.31 LP(1)N15 BD * (1)C10-H22 0.91 CH 3 CH 2 OH LP(1)O11 BD * (1)C2-C3 6.50 LP(2)O11 BD * (2)C1-C2 28.70 LP(1)O14 BD * (1)C8-C9 2.53 LP(1)O14 BD * (1)C9-O13 1.45 LP(2)O14 BD * (1)C8-C9 19.24 LP(2)O14 BD * (1)C9-O13 34.02 LP(1)N15 BD * (1)C7-C8 0.97 LP(1)N15 BD * (1)C8-C9 0.93 LP(1)N15 BD * (1)C8-C10 8.31 LP(1)N15 BD * (1)C10-H22 0.91 investigation of solvent effects on the structural stability and accurate theoretical NMR data of compounds (Witanowski et al., 1990 (Witanowski et al., , 1990 ). As we know the effect of solvent molecules on methyldopa plays an important role in the chemical behavior of methyldopa we have already presented the results of our extensive studies of solvent induced effects on the NMR shielding of methyldopa. Nuclear magnetic resonance (NMR) is based on the quantum mechanical property of nuclei (Benas et al., 2000) . The chemical shielding refers to the phenomenon which is associated with the secondary magnetic field created by the induced motions of the electrons that surround the nuclei when in the presence of an applied magnetic moment l in a magnetic field, B, is as follows:
where the shielding r iso the differential resonance shift due to the induced motion of the electrons (Magdalena and Sadlej Joanna, 1998) . In general, the electron distribution around a nucleus in a molecule is more spherically symmetric. Therefore, the size of electron current around the field, and hence the size of the shielding, will depend on the orientation of the molecule within the applied field B (Melinda, 2003) . For chemical shielding (CS) tensor which describes how the size of shielding varies with molecular orientation, we often use the following convention for the three principal components:
The three values of the shielding tensor are frequently expressed as the isotropic value r iso and their quantities are defined as follows Sojo et al., 2000 . The anisotropy (Dr) 
BD * (1)C8-C10 8.33 LP(1)N15 BD * (1)C10-H22 0.84 CH 3 CH 2 OH LP(1)O11 BD * (1)C2-C3 5.08 LP(2)O11 BD * (2)C1-C2 24.15 LP(1)O14 BD * (1)C8-C9 2.60 LP(1)O14 BD * (1)C9-O13 1.20 LP(2)O14 BD * (1)C8-C9 15.00 LP(2)O14 BD * (1)C9-O13 31.64 LP(1)N15 BD * (1)C7-C8 1.35 LP(1)N15 BD * (1)C8-C9 0.89 LP(1)N15 BD * (1)C8-C10 8.33 LP(1)N15 BD * (1)C10-H22 0.84 BD * (1)C7-C8 0.76 LP(1)N15 BD * (1)C8-C9 0.72 LP(1)N15 BD * (1)C8-C10 7.10 LP(1)N15 BD * (1)C10-H22 0.78 CH 3 CH 2 OH LP(1)O11 BD * (1)C2-C3 5.64 LP(2)O11 BD * (2)C1-C2 24.90 LP(1)O14 BD * (1)C8-C9 2.43 LP(1)O14 BD * (1)C9-O13 1.35 LP(2)O14 BD * (1)C8-C9 16.93 LP(2)O14 BD * (1)C9-O13 30.03 LP(1)N15 BD * (1)C7-C8 0.76 LP(1)N15 BD * (1)C8-C9 0.72 LP(1)N15 BD * (1)C8-C10 7.10 LP(1)N15 BD * (1)C10-H22 0.78
(1) The isotropic value r iso r iso ¼ 1=3ðr 11 þ r 22 þ r 33 Þ ð 4Þ
(1) The anisotropy shielding Dr
Instead of deriving (rD ind ) from the difference of the PCMoptimized in vacuum, it can be obtained from the shielding calculated in vacuum for a molecule that is geometry -optimized in solution (Monajjemi et al., 2007) , thus:
where r vac (Rsol) is the value of nuclear shielding in vacuum but with the solute geometry optimized in solution r vac (Rref) is the corresponding parameter for calculation with reference solvent. in this case, we may suppose that optimization of solute molecule in solvent and then performing shielding calculation is similar to shielding calculations in the isolated system (Lynden, 1997). Self -consistent reaction field (SCRF) method is based on a continuum model with uniform dielectric constant (e). The simplest SCRF model is the Onsager reaction field model. In this method, the solute occupies a fixed spherical cavity of radius a within the solvent field. A dipole in the molecule will induce a dipole in the medium, and the electric field applied by the solvent dipole will in turn interact with the molecular dipole leading to net stabilization. The Gauge Including Atomic Orbital (GIAO) approach was used. The abinitio GIAO calculations of NMR chemical shielding tensors were calculated with the GAUSSIAN 98 W program.
The isotropic chemical shielding (r iso ) and anisotropy shielding (Dr) for C8-N15,C9‚O14 and C2-O11 atoms have been summarized in Tables 3-5-3-16. C8-N15, C9‚O14 and C2-O11 atoms are very important in this structure, because these atoms are agent bonding methyldopa.
In the NBO analysis, in order to compute the span of the valence space, each valence bonding NBO (r AB ), must in turn, be paired with a corresponding valence anti bonding NBO (r * AB ): Namely, the Lewis r-type (donor) NBO are complemented by the non-Lewis r * -type (acceptor) NBO that are formally empty in an idealized Lewis structure picture. Readily, the general transformation to NBO leads to orbital's that are BD * (1)C7-C8 1.20 LP(1)N15 BD * (1)C8-C9 1.24 LP(1)N15 BD * (1)C8-C10 10.80 LP(1)N15 BD * (1)C10-H22 1.10 unoccupied in the formal Lewis structure. As a result, the filled NBO of the natural Lewis structure is well adapted to describe covalency effects in molecules. Since the non-covalent delocalization effects are associated with r fi r * interactions between filled (donor) and unfilled (acceptor) orbital's, it is natural to describe them as being of donor-acceptor, charge transfer, or generalized ''Lewis base-Lewis acid'' type. The anti bonds represent unused valence-shell capacity and spanning portions of the atomic valence space that are formally unsaturated by covalent bond formation. Weak occupancies of the valence anti bonds signal irreducible departures from an idealized localized Lewis picture, i.e. true ''delocalization effects''. As a result, in the NBO analysis, the donor-acceptor (bond-anti bond) interactions are taken into consideration by examining all possible interactions between 'filled' (donor) Lewis-type NBO and 'empty' (acceptor) non-Lewis NBO and then estimating their energies by second-order perturbation theory. These interactions (or energetic stabilizations) are referred to as 'delocalization' corrections to the zeroth-order natural Lewis structure. The most important interaction between ''filled'' (donor) Lewis-type NBO and ''empty'' (acceptor) non-Lewis is reported in Tables 3-17-3-23 the level of B3LYP, BLYP and MP2(3-21G,6-31G,6-31G * ) basis set at the DFT theory, we observed between the LP(1) N15 and r * (1) of C7-C8 of methyldopa LP(1) O11 and r * (1) of C2-C3 methyldopa and finally we reported the energy of methyldopa in Tables 3-17-3-23 by  same level.  Tables 3-24-3-35 show calculated natural orbital occupancy (number of electron, or ''natural population'' of the orbital). It is noted that for rC8-N15 bond orbital, decreased Table 3 -25 Occupancy and energy (kcal/mol) and hybrid for r (C8-N15) atoms from methyldopa structure in H 2 O phase.
Method
Bond Hybrid Occupancy Energy B3LYP/3-21G * C8-N15(water) BD(1) C8 = Sp 3.64 1.98251 À0.70176 N15 = sp 2.23 B3LYP/6-31G C8-N15(water) BD(1) C8 = sp 3.34 1.98351 À0.72048 N15 = sp 1.96 B3LYP/6-31G * C8-N15(water) BD(1) C8 = sp 3.34 1.98382 À0.70787 N15 = sp 2.17 BLYP/3-21G * C8-N15(water) BD(1) C8 = sp 3.65 1.98143 À0.61935 N15 = sp 2.37 BLYP/6-31G C8-N15(water) BD(1) C2 = sp 3.36 1.98323 À0.64037 O11 = sp 2.02 BLYP/6-31G * C8-N15(water) BD(1) C2 = sp 3.36 1.98331 À0.62528 O11 = sp 2.26 MP2/3-21G * C8-N15(water) BD(1) C2 = sp 3.72 1.95510 -O11 = sp 2.36 MP2/6-31G C8-N15(water) BD(1) C2 = sp 3.43 1.95489 -O11 = sp 2.07 MP2/6-31G * C8-N15(water) BD(1) C2 = sp 3.38 1.94810 -O11 = sp 2.19 Table 3 -26 Occupancy and energy (kcal/mol) and hybrid for r (C8-N15) atoms from methyldopa structure in methanol phase.
Bond Hybrid Occupancy Energy B3LYP/3-21G * C8-N15(methanol) BD(1) C8 = Sp 3.64 1.98251 À0.70170 N15 = sp 2.23 B3LYP/6-31G C8-N15(methanol) BD(1) C8 = sp 3.34 1.98351 À0.72041 N15 = sp 1.96 B3LYP/6-31G * C8-N15(methanol) BD(1) C8 = sp 3.34 1.98382 À0.70775 N15 = sp 2.17 BLYP/3-21G * C8-N15(methanol) BD(1) C8 = sp 3.65 1.98147 À0.61866 N15 = sp 2.38 BLYP/6-31G C8-N15(methanol) BD(1) C2 = sp 3.36 1.98323 À0.64028 O11 = sp 2.02 BLYP/6-31G * C8-N15(methanol) BD(1) C2 = sp 3.36 1.98331 À0.62518 O11 = sp 2.26 MP2/3-21G * C8-N15(methanol) BD(1) C2 = sp 3.71 1.95510 -O11 = sp 2.37 MP2/6-31G C8-N15(methanol) BD(1) C2 = sp 3.43 1.95489 -O11 = sp 2.07 MP2/6-31G * C8-N15(methanol) BD(1) C2 = sp 3.38 1.94810 -O11 = sp 2.19 Table 3 -27 Occupancy and energy (kcal/mol) and hybrid for r (C8--N15) atoms from methyldopa structure in ethanol phase.
Bond Hybrid Occupancy Energy B3LYP/3-21G * C8-N15(ethanol) BD(1) C8 = Sp 3.64 1.98251 À0.70167 N15 = sp 2.23 B3LYP/6-31G C8-N15(ethanol) BD(1) C8 = sp 3.34 1.98351 À0.72037 N15 = sp 1.96 B3LYP/6-31G * C8-N15(ethanol) BD(1) C8 = sp 3.34 1.98382 À0.70769 N15 = sp 2.17 BLYP/3-21G * C8-N15(ethanol) BD(1) C8 = sp 3.65 1.98147 À0.61863 N15 = sp 2.38 BLYP/6-31G C8-N15(ethanol) BD(1) C2 = sp 3.36 1.98323 À0.64023 O11 = sp 2.02 BLYP/6-31G * C8-N15(ethanol) BD(1) C2 = sp 3.36 1.98331 À0.62513 O11 = sp 2.26 MP2/3-21G * C8-N15(ethanol) BD(1) C2 = sp 3.72 1.95510 -O11 = sp 2.36 MP2/6-31G C8-N15(ethanol) BD(1) C2 = sp 3.44 1.95489 -O11 = sp 2.07 MP2/6-31G * C8-N15(ethanol) BD(1) C2 = sp 3.38 1.94810 -O11 = sp 2.19 Table 3 -28 Occupancy and energy (kcal/mol) and hybrid for r (C9‚O14) atoms from methyldopa structure in gas phase. BD(2) C9 = SP 1.00 1.94391 -O14 = SP 1.00 MP2/6-31G C9‚O14 (methanol) BD(2) C9 = SP 1.00 1.94100 -O14 = SP1 .00 MP2/6-31G * C9‚O14 (methanol) BD(2) C9 = SP 1.00 1.94057 -O14 = SP 1.00 Table 3 -32 Occupancy and energy (kcal/mol) and hybrid for r (C2-O11) atoms from methyldopa structure in gas phase.
Bond Hybrid Occupancy Energy B3LYP/3-21G * C2-O11(gas) BD(1) C2 = Sp 3.11 1.99299 À0.88826 O11 = sp 2.22 B3LYP/6-31G C2-O11 (gas) BD(1) C2 = sp 13.06 1.99330 À0.88785 O11 = sp 2.09 B3LYP/6-31G C2-O11 (gas) BD(1) C2 = sp 2.96 1.99401 À0.89468 O11 = sp 1.96 BLYP/3-21G * C2-O11 (gas) BD(1) C2 = sp 3.12 1.90250 À0.79071 O11 = sp 2.42 BLYP/6-31G C2-O11 (gas) BD(1) C2 = sp 3.10 1.99335 À0.79082 O11 = sp 2.25 BLYP/6-31G * C2-O11 (gas) BD(1) C2 = sp 2.99 1.99373 À0.79718 O11 = sp 2.09 MP2/3-21G * C2-O11 (gas) BD(1) C2 = sp 3.04 1.99402 À1.11491 O11 = sp 2.25 MP2/6-31G C2-O11 (gas) BD(1) C2 = sp 3.01 1.99397 À1.11360 O11 = sp 2.16 MP2/6-31G * C2-O11gas) BD(1) C2 = sp 2.92 1.99486 À1.15333 O11 = sp 1.92 Table 3 -33 Occupancy and energy (kcal/mol) and hybrid for r (C2-O11) atoms from methyldopa structure in H 2 O phase.
Bond Hybrid Occupancy Energy B3LYP/3-21G * C2-O11(water) BD(1) C2 = Sp 3.11 1.99305 À0.88670 O11 = sp 2.21 B3LYP/6-31G C2-O11 (water) BD(1) C2 = sp 3.07 1.99337 À0.88614 O11 = sp 2.08 B3LYP/6-31G C2-O11 water) BD(1) C2 = sp 2.97 1.99406 À0.89148 O11 = sp 1.96 BLYP/3-21G * C2-O11 (water) BD(1) C2 = sp 3.13 1.99256 À0.78792 O11 = sp 2.41 BLYP/6-31G C2-O11 (water) BD(1) C2 = sp 3.10 1.99312 À0.78818 O11 = sp 2.24 BLYP/6-31G * C2-O11 (water) BD(1) C2 = sp 2.99 1.99377 À0.79407 O11 = sp 2.08 MP2/3-21G * C2-O11 (water) BD(1) C2 = sp 3.07 1.96698 -O11 = sp 2.38 MP2/6-31G C2-O11 (water) BD(1) C2 = sp 3.03 1.96526 -O11 = sp 2.28 MP2/6-31G * C2-O11 (water) BD(1) C2 = sp 2.93 1.96210 -O11 = sp 2.06 or increased occupancy of the localized rC9‚O15 bond orbital in the idealized Lewis structure, and their subsequent impact on molecular stability and geometry (bond lengths) are also related with the resulting p character of the corresponding O29 natural hybrid orbital (NHO) of rC2-O110 bond orbital.
Frequency calculations
The vibrational frequencies of methyldopa were calculated at the, DFT (B3LYP, BLYP) and MP2 levels of theory using the 3-21G * ,6-31G,6-31G * basis set (Jensen James, 2005) . The entropies and heat capacities were calculated using statistical mechanics based on the vibrational frequencies (Zheng et al., 2005) . The nature of all stationary point structures was determined by analytical frequency analysis, which also provide zero-point vibrational energies (ZPEs) (Cherkaoui and Boutalib, 2006) . Electronic energies, enthalpies, Gibbs free energies and zero point vibrational energies for both the compounds using frequency calculation at 298.15 K and 310.15 K temperatures are presented in Tables 3-36-3-39. Thermo chemistry analysis follows the frequency and normal mode data. Sum of electronic and zero-point energies = DE°+ E ZPE Sum of electronic and thermal energies = DE°+ E tot Sum of electronic and thermal enthalpies = DE°þ Hcorr Sum of electronic and thermal free energies = DE°X ± G corr where DE°is the total electronic energy at T = 0 K, G corr and H corr which represents the thermal correction to Gibbs free energy and enthalpy, respectively. The internal thermal energy E tot is contributed from translational (E t ), rotational (E r ), vibrational (E v ), and electronic (E e ) energies, and S tot , S t , S r , S v , S e are their corresponding entropies . The next sections about the individual contribution to the internal thermal energy (E tot ), constant volume molar heat capacity (C v ) tot , entropy (S tot ) and Partition function (Q) Ochterski, 2000. The partition functions are also computed, with both bottom of the vibrational well and lowest (zero-point) vibrational state as reference. The comparison of thermo chemistry values was calculated for two structures, which shows that with increasing temperature, these values increase in both structures and also these values for methyldopa at two temperatures are more than methyldopa which shows the greater stability of methyldopa.
Conclusion
In this research we have calculated quantum calculations on antihypertensive drugs such as Opt, NMR, NBO and IR and the results of these calculations have been summarized in Tables 3-1-3-4. The main difference of methyldopa is in C8-N15, C9‚O14 and C2-O11 bonds (Fig. 1 ) and the structural details of these bonds have been reported in tables which are based on our calculations. In fact these calculations are considered as a model and if a molecule has these properties which have been mentioned in this paper and their data calculations are similar to data calculations of this paper we can call it as a new antihypertensive drug and in the next stage for more surety it is possible to test and synthesize it in the laboratory.
(1) we conclude from the calculations opt stable state with the solvent ethanol is BLYP/3-21G * basis set.
(2) we conclude by the calculations that NMR r iso for atoms: C8-N15, C2-O11, C9‚O14 and Dr for atoms: C2-O11, C9‚O14, and C8-N15 are related to the solvent ethanol.
(r iso ) for C8 = 136.2307, N15 = 208.4537, C9 = 36.3880, O14 = À55.5087, C2 = 67.0383, O11 = 215.1109 and Dr for C8 = À282.386, N15 = À3413.925, C9 = À4971.069, O14 = 56658.707, C2 = 2259.005, O11 = À7794.946).
(3) From the hybridation calculations of NBO, we conclude the links to the following atoms C8-N15, C9 = O14, and C2-O11 are related to the solvent ethanol. (C8 = sp 3.65 ,N15 = sp 2.38 , C9 = sp 99.99 ,O14 = sp 99.99 , C2 = sp 3.12 , O11 = sp 2.41 ). (4) The comparison of thermo chemistry parameters of structures that are expressed in Tables 3-36-3-39 show that with increasing temperature, the thermal correction to Gibbs free energy and enthalpy (G corr , H corr ), the internal thermal energy (E tot ), constant volume molar heat capacity (C v ) tot, entropy (S tot ) and the individual contributions to the internal thermal energy (E tot ) increase in structure and from these parameter values for methyldopa we conclude that most frequencies of IR calculations for atoms C9 = O14 = C8-N15 = C2-O11 are related to the solvent ethanol frequency calculations and we conclude that the links are as follows: C8-N15:783.6411, C9‚O14:783.6411, C2-O11:783.6411.
